25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

SEQUENT SCIENTIFIC LTD.
Buy, Hold or Sell?

Let's analyze Sequent together

I guess you are interested in SEQUENT SCIENTIFIC LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of SEQUENT SCIENTIFIC LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about SEQUENT SCIENTIFIC LTD.

I send you an email if I find something interesting about SEQUENT SCIENTIFIC LTD..

1. Quick Overview

1.1. Quick analysis of Sequent (30 sec.)










1.2. What can you expect buying and holding a share of Sequent? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
75.0%

What is your share worth?

Current worth
INR28.59
Expected worth in 1 year
INR30.91
How sure are you?
62.5%

+ What do you gain per year?

Total Gains per Share
INR2.31
Return On Investment
1.1%

For what price can you sell your share?

Current Price per Share
INR201.70
Expected price per share
INR155.45 - INR240.90
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Sequent (5 min.)




Live pricePrice per Share (EOD)
INR201.70
Intrinsic Value Per Share
INR-37.73 - INR-28.20
Total Value Per Share
INR-9.14 - INR0.39

2.2. Growth of Sequent (5 min.)




Is Sequent growing?

Current yearPrevious yearGrowGrow %
How rich?$84.1m$82.4m$1.6m2.0%

How much money is Sequent making?

Current yearPrevious yearGrowGrow %
Making money-$4.2m-$14.2m$10m237.8%
Net Profit Margin-2.6%-8.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Sequent (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Sequent?

Welcome investor! Sequent's management wants to use your money to grow the business. In return you get a share of Sequent.

First you should know what it really means to hold a share of Sequent. And how you can make/lose money.

Speculation

The Price per Share of Sequent is INR201.70. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sequent.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sequent, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR28.59. Based on the TTM, the Book Value Change Per Share is INR0.58 per quarter. Based on the YOY, the Book Value Change Per Share is INR0.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sequent.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.020.0%-0.020.0%-0.060.0%0.000.0%0.030.0%
Usd Book Value Change Per Share0.010.0%0.010.0%0.000.0%0.000.0%0.040.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.0%0.010.0%0.000.0%0.000.0%0.040.0%
Usd Price Per Share1.34-1.34-1.03-1.42-1.25-
Price to Earnings Ratio-79.14--79.14--18.04-14.05--7.14-
Price-to-Total Gains Ratio196.94-196.94-339.05-64.73-43.25-
Price to Book Ratio3.98-3.98-3.13-4.26-3.65-
Price-to-Total Gains Ratio196.94-196.94-339.05-64.73-43.25-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.38006
Number of shares420
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.00
Gains per Quarter (420 shares)2.871.42
Gains per Year (420 shares)11.465.69
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1011151-4
202312922
3034231438
40463419414
50574523520
60695628626
70806733732
80927838838
901038942944
100115100471050

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%5.03.00.062.5%5.03.00.062.5%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%5.03.00.062.5%5.03.00.062.5%
Dividend per Share0.00.01.00.0%1.00.02.033.3%3.00.02.060.0%6.00.02.075.0%6.00.02.075.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%5.03.00.062.5%5.03.00.062.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of SEQUENT SCIENTIFIC LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.5780.5780%0.259+124%0.050+1050%3.574-84%
Book Value Per Share--28.59328.5930%28.015+2%28.220+1%29.323-2%
Current Ratio--1.3121.3120%1.501-13%1.464-10%1.381-5%
Debt To Asset Ratio--0.5370.5370%0.543-1%0.522+3%0.513+5%
Debt To Equity Ratio--1.2601.2600%1.188+6%1.117+13%1.072+18%
Dividend Per Share----0%-0%0.237-100%0.221-100%
Eps---1.439-1.4390%-4.857+238%0.396-464%2.535-157%
Free Cash Flow Per Share---0.009-0.0090%-2.781+32611%0.522-102%0.341-102%
Free Cash Flow To Equity Per Share---0.009-0.0090%-1.489+17414%-0.136+1497%0.282-103%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---28.198--------
Intrinsic Value_10Y_min---37.730--------
Intrinsic Value_1Y_max---0.200--------
Intrinsic Value_1Y_min---1.684--------
Intrinsic Value_3Y_max---2.602--------
Intrinsic Value_3Y_min---6.907--------
Intrinsic Value_5Y_max---7.417--------
Intrinsic Value_5Y_min---14.112--------
Market Cap50293895000.000+44%28388497500.00028388497500.0000%21862846275.000+30%30050632255.000-6%26334677957.500+8%
Net Profit Margin---0.026-0.0260%-0.085+226%0.009-379%0.071-137%
Operating Margin----0%-0.0110%0.052-100%0.053-100%
Operating Ratio--1.5491.5490%1.657-6%1.514+2%1.273+22%
Pb Ratio7.054+44%3.9823.9820%3.129+27%4.256-6%3.649+9%
Pe Ratio-140.215-77%-79.145-79.1450%-18.045-77%14.049-663%-7.142-91%
Price Per Share201.700+44%113.850113.8500%87.650+30%120.510-6%105.610+8%
Price To Free Cash Flow Ratio-23723.535-77%-13390.801-13390.8010%-31.516-100%-3095.414-77%-2079.589-84%
Price To Total Gains Ratio348.902+44%196.938196.9380%339.052-42%64.734+204%43.250+355%
Quick Ratio--0.5510.5510%0.727-24%0.776-29%0.768-28%
Return On Assets---0.023-0.0230%-0.079+240%0.008-377%0.048-149%
Return On Equity---0.055-0.0550%-0.173+217%0.013-526%0.096-157%
Total Gains Per Share--0.5780.5780%0.259+124%0.287+101%3.795-85%
Usd Book Value--84129162.00084129162.0000%82455804.000+2%83038724.000+1%86282337.500-2%
Usd Book Value Change Per Share--0.0070.0070%0.003+124%0.001+1050%0.042-84%
Usd Book Value Per Share--0.3370.3370%0.331+2%0.333+1%0.346-2%
Usd Dividend Per Share----0%-0%0.003-100%0.003-100%
Usd Eps---0.017-0.0170%-0.057+238%0.005-464%0.030-157%
Usd Free Cash Flow---25016.000-25016.0000%-8185778.000+32622%1535888.000-102%1002144.500-102%
Usd Free Cash Flow Per Share--0.0000.0000%-0.033+32611%0.006-102%0.004-102%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%-0.018+17414%-0.002+1497%0.003-103%
Usd Market Cap593467961.000+44%334984270.500334984270.5000%257981586.045+30%354597460.609-6%310749199.899+8%
Usd Price Per Share2.380+44%1.3431.3430%1.034+30%1.422-6%1.246+8%
Usd Profit---4232542.000-4232542.0000%-14296762.000+238%1162866.400-464%7458721.000-157%
Usd Revenue--161628258.000161628258.0000%167667262.000-4%159165834.000+2%137500621.000+18%
Usd Total Gains Per Share--0.0070.0070%0.003+124%0.003+101%0.045-85%
 EOD+6 -2MRQTTM+0 -0YOY+25 -75Y+15 -2010Y+7 -28

3.3 Fundamental Score

Let's check the fundamental score of SEQUENT SCIENTIFIC LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-140.215
Price to Book Ratio (EOD)Between0-17.054
Net Profit Margin (MRQ)Greater than0-0.026
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.551
Current Ratio (MRQ)Greater than11.312
Debt to Asset Ratio (MRQ)Less than10.537
Debt to Equity Ratio (MRQ)Less than11.260
Return on Equity (MRQ)Greater than0.15-0.055
Return on Assets (MRQ)Greater than0.05-0.023
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of SEQUENT SCIENTIFIC LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.849
Ma 20Greater thanMa 50194.713
Ma 50Greater thanMa 100193.018
Ma 100Greater thanMa 200170.404
OpenGreater thanClose190.500
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About SEQUENT SCIENTIFIC LTD.

Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics, including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that support API, pharmaceutical, personal care, and nutraceutical organizations; and method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009. The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.

Fundamental data was last updated by Penke on 2024-11-14 05:12:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Sequent earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Sequent to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -2.6% means that ₹-0.03 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of SEQUENT SCIENTIFIC LTD.:

  • The MRQ is -2.6%. The company is making a loss. -1
  • The TTM is -2.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-2.6%0.0%
TTM-2.6%YOY-8.5%+5.9%
TTM-2.6%5Y0.9%-3.6%
5Y0.9%10Y7.1%-6.2%
4.3.1.2. Return on Assets

Shows how efficient Sequent is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sequent to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.3% Return on Assets means that Sequent generated ₹-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of SEQUENT SCIENTIFIC LTD.:

  • The MRQ is -2.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.3%TTM-2.3%0.0%
TTM-2.3%YOY-7.9%+5.6%
TTM-2.3%5Y0.8%-3.2%
5Y0.8%10Y4.8%-4.0%
4.3.1.3. Return on Equity

Shows how efficient Sequent is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sequent to the Drug Manufacturers - Specialty & Generic industry mean.
  • -5.5% Return on Equity means Sequent generated ₹-0.05 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of SEQUENT SCIENTIFIC LTD.:

  • The MRQ is -5.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.5%TTM-5.5%0.0%
TTM-5.5%YOY-17.3%+11.9%
TTM-5.5%5Y1.3%-6.7%
5Y1.3%10Y9.6%-8.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of SEQUENT SCIENTIFIC LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Sequent is operating .

  • Measures how much profit Sequent makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sequent to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of SEQUENT SCIENTIFIC LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1.1%+1.1%
TTM-5Y5.2%-5.2%
5Y5.2%10Y5.3%-0.1%
4.3.2.2. Operating Ratio

Measures how efficient Sequent is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.55 means that the operating costs are ₹1.55 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of SEQUENT SCIENTIFIC LTD.:

  • The MRQ is 1.549. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.549. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.549TTM1.5490.000
TTM1.549YOY1.657-0.108
TTM1.5495Y1.514+0.035
5Y1.51410Y1.273+0.241
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of SEQUENT SCIENTIFIC LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Sequent is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.31 means the company has ₹1.31 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of SEQUENT SCIENTIFIC LTD.:

  • The MRQ is 1.312. The company is just able to pay all its short-term debts.
  • The TTM is 1.312. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.312TTM1.3120.000
TTM1.312YOY1.501-0.189
TTM1.3125Y1.464-0.151
5Y1.46410Y1.381+0.083
4.4.3.2. Quick Ratio

Measures if Sequent is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sequent to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.55 means the company can pay off ₹0.55 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of SEQUENT SCIENTIFIC LTD.:

  • The MRQ is 0.551. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.551. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.551TTM0.5510.000
TTM0.551YOY0.727-0.177
TTM0.5515Y0.776-0.225
5Y0.77610Y0.768+0.007
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of SEQUENT SCIENTIFIC LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Sequent assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sequent to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.54 means that Sequent assets are financed with 53.7% credit (debt) and the remaining percentage (100% - 53.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of SEQUENT SCIENTIFIC LTD.:

  • The MRQ is 0.537. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.537. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.537TTM0.5370.000
TTM0.537YOY0.543-0.006
TTM0.5375Y0.522+0.015
5Y0.52210Y0.513+0.009
4.5.4.2. Debt to Equity Ratio

Measures if Sequent is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sequent to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 126.0% means that company has ₹1.26 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of SEQUENT SCIENTIFIC LTD.:

  • The MRQ is 1.260. The company is able to pay all its debts with equity. +1
  • The TTM is 1.260. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.260TTM1.2600.000
TTM1.260YOY1.188+0.072
TTM1.2605Y1.117+0.143
5Y1.11710Y1.072+0.046
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Sequent generates.

  • Above 15 is considered overpriced but always compare Sequent to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -79.14 means the investor is paying ₹-79.14 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of SEQUENT SCIENTIFIC LTD.:

  • The EOD is -140.215. Based on the earnings, the company is expensive. -2
  • The MRQ is -79.145. Based on the earnings, the company is expensive. -2
  • The TTM is -79.145. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-140.215MRQ-79.145-61.071
MRQ-79.145TTM-79.1450.000
TTM-79.145YOY-18.045-61.100
TTM-79.1455Y14.049-93.194
5Y14.04910Y-7.142+21.191
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of SEQUENT SCIENTIFIC LTD.:

  • The EOD is -23,723.535. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -13,390.801. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -13,390.801. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-23,723.535MRQ-13,390.801-10,332.735
MRQ-13,390.801TTM-13,390.8010.000
TTM-13,390.801YOY-31.516-13,359.285
TTM-13,390.8015Y-3,095.414-10,295.387
5Y-3,095.41410Y-2,079.589-1,015.825
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Sequent is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 3.98 means the investor is paying ₹3.98 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of SEQUENT SCIENTIFIC LTD.:

  • The EOD is 7.054. Based on the equity, the company is overpriced. -1
  • The MRQ is 3.982. Based on the equity, the company is fair priced.
  • The TTM is 3.982. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD7.054MRQ3.982+3.072
MRQ3.982TTM3.9820.000
TTM3.982YOY3.129+0.853
TTM3.9825Y4.256-0.274
5Y4.25610Y3.649+0.607
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets15,403,840
Total Liabilities8,274,250
Total Stockholder Equity6,565,600
 As reported
Total Liabilities 8,274,250
Total Stockholder Equity+ 6,565,600
Total Assets = 15,403,840

Assets

Total Assets15,403,840
Total Current Assets8,228,560
Long-term Assets7,175,280
Total Current Assets
Cash And Cash Equivalents 648,100
Short-term Investments 95,330
Net Receivables 3,356,310
Inventory 3,462,320
Other Current Assets 542,180
Total Current Assets  (as reported)8,228,560
Total Current Assets  (calculated)8,104,240
+/- 124,320
Long-term Assets
Property Plant Equipment 3,112,250
Goodwill 2,349,340
Intangible Assets 617,210
Long-term Assets Other 51,580
Long-term Assets  (as reported)7,175,280
Long-term Assets  (calculated)6,130,380
+/- 1,044,900

Liabilities & Shareholders' Equity

Total Current Liabilities6,269,900
Long-term Liabilities2,004,350
Total Stockholder Equity6,565,600
Total Current Liabilities
Short Long Term Debt 3,085,600
Accounts payable 2,602,590
Other Current Liabilities 339,280
Total Current Liabilities  (as reported)6,269,900
Total Current Liabilities  (calculated)6,027,470
+/- 242,430
Long-term Liabilities
Long term Debt 1,427,190
Capital Lease Obligations Min Short Term Debt364,140
Long-term Liabilities  (as reported)2,004,350
Long-term Liabilities  (calculated)1,791,330
+/- 213,020
Total Stockholder Equity
Total Stockholder Equity (as reported)6,565,600
Total Stockholder Equity (calculated)0
+/- 6,565,600
Other
Capital Stock498,860
Common Stock Shares Outstanding 249,021
Net Debt 3,864,690
Net Invested Capital 11,078,390
Net Working Capital 1,958,660
Property Plant and Equipment Gross 3,112,250



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
19,046,140
13,427,620
13,878,770
14,626,460
13,925,590
14,509,710
15,291,230
15,403,840
15,403,84015,291,23014,509,71013,925,59014,626,46013,878,77013,427,62019,046,140
   > Total Current Assets 
7,277,370
5,380,150
5,999,870
7,041,370
7,135,850
7,831,800
7,898,860
8,228,560
8,228,5607,898,8607,831,8007,135,8507,041,3705,999,8705,380,1507,277,370
       Cash And Cash Equivalents 
1,450
395,440
677,890
680,960
537,440
574,960
415,740
648,100
648,100415,740574,960537,440680,960677,890395,4401,450
       Short-term Investments 
647,060
173,450
4,700
401,790
59,590
16,250
510
95,330
95,33051016,25059,590401,7904,700173,450647,060
       Net Receivables 
2,643,520
2,719,410
2,812,740
3,187,640
3,461,370
3,292,410
3,409,620
3,356,310
3,356,3103,409,6203,292,4103,461,3703,187,6402,812,7402,719,4102,643,520
       Inventory 
1,608,070
1,585,740
2,001,030
2,194,170
2,643,570
3,479,740
3,528,550
3,462,320
3,462,3203,528,5503,479,7402,643,5702,194,1702,001,0301,585,7401,608,070
       Other Current Assets 
1,907,440
472,890
458,340
437,280
276,150
401,630
542,690
542,180
542,180542,690401,630276,150437,280458,340472,8901,907,440
   > Long-term Assets 
0
0
7,878,900
8,141,650
6,789,740
6,547,940
7,392,370
7,175,280
7,175,2807,392,3706,547,9406,789,7408,141,6507,878,90000
       Property Plant Equipment 
4,011,230
2,269,200
2,442,300
3,559,530
3,478,566
3,253,430
3,521,280
3,112,250
3,112,2503,521,2803,253,4303,478,5663,559,5302,442,3002,269,2004,011,230
       Goodwill 
2,242,370
2,021,930
2,209,720
1,823,180
1,742,010
1,807,840
2,400,420
2,349,340
2,349,3402,400,4201,807,8401,742,0101,823,1802,209,7202,021,9302,242,370
       Intangible Assets 
915,160
648,970
555,540
517,040
443,910
690,380
684,230
617,210
617,210684,230690,380443,910517,040555,540648,970915,160
       Long-term Assets Other 
0
0
0
190
2,724
8,970
49,280
51,580
51,58049,2808,9702,724190000
> Total Liabilities 
9,278,230
6,951,850
6,811,850
7,755,420
6,649,080
7,588,730
8,303,450
8,274,250
8,274,2508,303,4507,588,7306,649,0807,755,4206,811,8506,951,8509,278,230
   > Total Current Liabilities 
6,635,490
4,309,310
4,342,800
4,946,990
4,600,170
5,121,210
5,260,660
6,269,900
6,269,9005,260,6605,121,2104,600,1704,946,9904,342,8004,309,3106,635,490
       Short-term Debt 
1,947,000
1,524,070
1,273,620
1,471,210
1,029,050
1,595,430
1,820,890
0
01,820,8901,595,4301,029,0501,471,2101,273,6201,524,0701,947,000
       Short Long Term Debt 
0
0
1,687,030
1,805,890
1,300,850
1,924,360
2,150,980
3,085,600
3,085,6002,150,9801,924,3601,300,8501,805,8901,687,03000
       Accounts payable 
2,030,410
1,604,920
2,093,500
2,203,800
2,269,100
2,580,450
2,443,400
2,602,590
2,602,5902,443,4002,580,4502,269,1002,203,8002,093,5001,604,9202,030,410
       Other Current Liabilities 
2,068,490
658,630
428,640
703,700
898,140
462,750
519,010
339,280
339,280519,010462,750898,140703,700428,640658,6302,068,490
   > Long-term Liabilities 
0
0
2,076,080
2,612,060
1,553,390
1,889,610
2,538,670
2,004,350
2,004,3502,538,6701,889,6101,553,3902,612,0602,076,08000
       Long term Debt Total 
1,651,790
1,098,250
1,523,180
2,034,880
1,391,030
1,643,070
2,197,700
0
02,197,7001,643,0701,391,0302,034,8801,523,1801,098,2501,651,790
       Capital Lease Obligations Min Short Term Debt
-1,947,000
-1,524,070
-1,213,350
-863,990
-506,180
-1,095,340
-1,363,920
364,140
364,140-1,363,920-1,095,340-506,180-863,990-1,213,350-1,524,070-1,947,000
       Long-term Liabilities Other 
0
0
22,960
13,130
8,690
6,770
3,700
0
03,7006,7708,69013,13022,96000
> Total Stockholder Equity
9,767,910
6,475,770
7,066,920
6,871,040
7,276,510
6,920,980
6,987,780
6,565,600
6,565,6006,987,7806,920,9807,276,5106,871,0407,066,9206,475,7709,767,910
   Common Stock
487,470
487,470
493,740
496,740
496,740
496,740
498,860
0
0498,860496,740496,740496,740493,740487,470487,470
   Retained Earnings 
-1,991,740
-1,738,550
-1,250,120
-564,170
827,350
1,118,790
1,229,730
0
01,229,7301,118,790827,350-564,170-1,250,120-1,738,550-1,991,740
   Capital Surplus 
10,130,650
8,345,140
8,490,360
8,603,820
8,726,860
8,833,930
9,003,240
0
09,003,2408,833,9308,726,8608,603,8208,490,3608,345,14010,130,650
   Treasury Stock00000000
   Other Stockholders Equity 
1,181,980
-585,630
-505,720
-1,428,680
-2,685,010
-3,379,520
-3,686,340
0
0-3,686,340-3,379,520-2,685,010-1,428,680-505,720-585,6301,181,980



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue13,697,310
Cost of Revenue-7,597,470
Gross Profit6,099,8406,099,840
 
Operating Income (+$)
Gross Profit6,099,840
Operating Expense-13,620,390
Operating Income76,920-7,520,550
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense13,620,3900
 
Net Interest Income (+$)
Interest Income0
Interest Expense-480,860
Other Finance Cost-0
Net Interest Income-480,860
 
Pretax Income (+$)
Operating Income76,920
Net Interest Income-480,860
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-546,46076,920
EBIT - interestExpense = -480,860
-358,690
122,170
Interest Expense480,860
Earnings Before Interest and Taxes (EBIT)0-65,600
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-546,460
Tax Provision--250,330
Net Income From Continuing Ops-296,130-296,130
Net Income-358,690
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0480,860
 

Technical Analysis of Sequent
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sequent. The general trend of Sequent is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sequent's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of SEQUENT SCIENTIFIC LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 231.70 < 240.90.

The bearish price targets are: 164.65 > 157.60 > 155.45.

Tweet this
SEQUENT SCIENTIFIC LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of SEQUENT SCIENTIFIC LTD.. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

SEQUENT SCIENTIFIC LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of SEQUENT SCIENTIFIC LTD.. The current macd is 2.09677312.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sequent price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Sequent. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Sequent price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
SEQUENT SCIENTIFIC LTD. Daily Moving Average Convergence/Divergence (MACD) ChartSEQUENT SCIENTIFIC LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of SEQUENT SCIENTIFIC LTD.. The current adx is 17.91.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sequent shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
SEQUENT SCIENTIFIC LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of SEQUENT SCIENTIFIC LTD.. The current sar is 221.36.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
SEQUENT SCIENTIFIC LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of SEQUENT SCIENTIFIC LTD.. The current rsi is 53.85. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
SEQUENT SCIENTIFIC LTD. Daily Relative Strength Index (RSI) ChartSEQUENT SCIENTIFIC LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of SEQUENT SCIENTIFIC LTD.. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sequent price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
SEQUENT SCIENTIFIC LTD. Daily Stochastic Oscillator ChartSEQUENT SCIENTIFIC LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of SEQUENT SCIENTIFIC LTD.. The current cci is 20.28.

SEQUENT SCIENTIFIC LTD. Daily Commodity Channel Index (CCI) ChartSEQUENT SCIENTIFIC LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of SEQUENT SCIENTIFIC LTD.. The current cmo is 9.06634267.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
SEQUENT SCIENTIFIC LTD. Daily Chande Momentum Oscillator (CMO) ChartSEQUENT SCIENTIFIC LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of SEQUENT SCIENTIFIC LTD.. The current willr is -62.1761658.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Sequent is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
SEQUENT SCIENTIFIC LTD. Daily Williams %R ChartSEQUENT SCIENTIFIC LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of SEQUENT SCIENTIFIC LTD..

SEQUENT SCIENTIFIC LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of SEQUENT SCIENTIFIC LTD.. The current atr is 11.34.

SEQUENT SCIENTIFIC LTD. Daily Average True Range (ATR) ChartSEQUENT SCIENTIFIC LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of SEQUENT SCIENTIFIC LTD.. The current obv is 17,946,270.

SEQUENT SCIENTIFIC LTD. Daily On-Balance Volume (OBV) ChartSEQUENT SCIENTIFIC LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of SEQUENT SCIENTIFIC LTD.. The current mfi is 48.23.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
SEQUENT SCIENTIFIC LTD. Daily Money Flow Index (MFI) ChartSEQUENT SCIENTIFIC LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for SEQUENT SCIENTIFIC LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

SEQUENT SCIENTIFIC LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of SEQUENT SCIENTIFIC LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.849
Ma 20Greater thanMa 50194.713
Ma 50Greater thanMa 100193.018
Ma 100Greater thanMa 200170.404
OpenGreater thanClose190.500
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Sequent with someone you think should read this too:
  • Are you bullish or bearish on Sequent? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sequent? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about SEQUENT SCIENTIFIC LTD.

I send you an email if I find something interesting about SEQUENT SCIENTIFIC LTD..


Comments

How you think about this?

Leave a comment

Stay informed about SEQUENT SCIENTIFIC LTD..

Receive notifications about SEQUENT SCIENTIFIC LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.